Effects of risedronate on fracture risk in postmenopausal women with osteopenia

SUMMARY: This posthoc analysis of four trials studied the efficacy of risedronate to reduce fragility fractures in postmenopausal women with osteopenia (i.e., T-scores between −1 and −2.5). Risedronate reduced the fracture risk by 73% ( = 0.023) in this population of women with low femoral neck bone...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Siris, E. S., Simon, J. A., Barton, I. P., McClung, M. R., Grauer, A.
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2007
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2277453/
https://ncbi.nlm.nih.gov/pubmed/17968610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-007-0493-y
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki